Results 241 to 250 of about 1,940,460 (362)

Differences between Newborn and Adult Mice in Their Response to Immune Thrombocytopenia [PDF]

open access: bronze, 2010
Zhongbo Hu   +5 more
openalex   +1 more source

The Role of Chatbots in Enquiry‐Based Learning for Oral Health Students—An Exploratory Study

open access: yesEuropean Journal of Dental Education, EarlyView.
ABSTRACT Objective This study explores the reliability of four Chatbots in enquiry‐based learning. Four Chatbots, namely Microsoft Copilot, Google Gemini, ChatGPT 3.5 and Perplexity, were used to answer and generate questions in four specific subject areas.
Rohini Khareedi, Daniel Fernandez
wiley   +1 more source

The Clinicopathologic Spectrum of Rosai–Dorfman–Destombes Disease in Adults: An Analysis of 16 Cases

open access: yesEuropean Journal of Haematology, EarlyView.
ABSTRACT Rosai–Dorfman–Destombes disease (RDD) is a rare histiocytic proliferation with protean clinical manifestations, resulting from the accumulation of activated histiocytes within nodal and extra‐nodal tissues. The diagnosis can be missed, particularly when biopsies are obtained from extra‐nodal sites, where histological features may be less ...
Mark Trinder   +8 more
wiley   +1 more source

Teclistamab-Induced Remission of Chronic Immune Thrombocytopenia in a Patient With Multiple Myeloma. [PDF]

open access: yesEJHaem
Quevedo-Salazar R   +6 more
europepmc   +1 more source

From Trials to Practice: A 2025 Review of Idecabtagene Vicleucel and Ciltacabtagene Autoleucel Efficacy Across Clinical Studies and Real‐World Evidence

open access: yesEuropean Journal of Haematology, EarlyView.
ABSTRACT B‐cell maturation antigen (BCMA)‐directed chimeric antigen receptor (CAR) T‐cell therapies have revolutionized the approach and management of relapsed/refractory multiple myeloma (RRMM), and as of 2025, idecabtagene vicleucel (ide‐cel) and ciltacabtagene autoleucel (cilta‐cel) are the only BCMA‐targeted CAR T‐cell therapies approved by the FDA.
Hector Garcia Pleitez   +5 more
wiley   +1 more source

Correction: A phase 3 study of the efficacy and safety of avatrombopag in Japanese adults with chronic immune thrombocytopenia. [PDF]

open access: yesInt J Hematol
Yamaguchi H   +14 more
europepmc   +1 more source

Reduced dose prednisone plus eltrombopag for the treatment of newly diagnosed adult primary immune thrombocytopenia: A prospective, multicentre, phase 2 clinical trial

open access: yes
British Journal of Haematology, EarlyView.
Qi Liu   +23 more
wiley   +1 more source

Bruton Tyrosine Kinase Inhibitors in Mantle Cell Lymphoma: What Are the Current Options?

open access: yesEuropean Journal of Haematology, EarlyView.
ABSTRACT Mantle Cell Lymphoma (MCL) is an aggressive B‐cell non‐Hodgkin lymphoma characterized by the hallmark t(11;14)(q13;q32) translocation, resulting in cyclin D1 overexpression. Predominantly affecting elderly males, MCL exhibits marked clinical and biological heterogeneity, ranging from indolent SOX11‐negative variants to highly proliferative ...
Santino Caserta   +10 more
wiley   +1 more source

Home - About - Disclaimer - Privacy